Postbiotica | News
POSTBIOTICA is an innovative Biopharmaceutical Company born to develop a new therapeutic treatments based on new molecules with a high biological impact called POSTBIOTICS. We hold a new fermentative process in which we design e modulate the Postbiotics productions.
postbiotica, postbiotics, postbiotics productions, biopharmaceutical company
49
archive,category,category-news,category-49,ajax_fade,page_not_loaded,,qode-theme-ver-16.7,qode-theme-bridge,wpb-js-composer js-comp-ver-5.5.2,vc_responsive
 

News

Postbiotica has signed a licensing agreement with Kalichem(a Lamberti company) leader in the dermocosmetic market, based on a well established R&D collaboration.   Kalichem develops and commercializes functional ingredients for cosmetics and medical devices. The agreement relates to the licensing of Postbtiocs-based products, obtained through our...

Postbiotica has signed a licensing and commercialising agreement with Candioli Pharma, a company leader in the pet-care market. The agreement foresees the exclusivity of the postbiotic ImmunoFOS® as an active ingredient to develop innovative nutraceuticals for pet healthcare. Thanks to this partnership Postbiotica aims to expand...

Gut bacteria depend fully on their host to provide the necessary nutrients that may promote microbiota growth. However, bacteria produce small molecular weight metabolites during their lifecycle; these compounds play a key role in regulating self-growth, development, reproduction, encourage the growth of other beneficial organism,...

The human gut is the habitat to trillions of microbial cells with over 1,000 diverse microbial species that contribute to the primary functions of the gastrointestinal tract, including nutrition and defense. On the other hand, the gastrointestinal tract mucosa constitutes the major interface that separates...

Postbiotica, represented by Francesca Algieri, won the first edition of the My Start BCN contest and has been rewarded by the President of the Chamber of Commerce, Igor Garzesi. Postbiotica has impressed the jury for the development of new metabolities derivated from bacterial fermentation and used ...

Postbiotica has presented the new technology to modulate the production of bacterial metabolites, called Postbiotics. Postbiotica has been selected among 151 projects by Bioupper. Bioupper is a training and acceleration platform and converts and enhances he best ideas for entrepreneurial initiatives. It is an initiative promoted by Novartis...

Maria Rescigno, professor and entrepreneur, co-founder of POSTBIOTICA, an innovative biopharmaceutical StartUp winner of the "MYSTART BCN" competition, is interviewed by  "Italiani Anywhere". [embed]https://www.italianiovunque.com/2017/11/maria-rescigno/[/embed]...